Can Angiosome-Based Revascularization Have An Impact In Limb Salvage?
- Volume 25 - Issue 3 - March 2012
- 19314 reads
- 2 comments
Subjecting patients to multiple digital and foot amputations, that in hindsight turn out to be futile, is taxing on patients, providers and even the healthcare system. Increasing the odds for success through the utilization of angiosomes and targeted revascularization is likely to prove an important next step in the evolution of lower extremity preservation.
Dr. Bell is a board certified wound specialist of the American Academy of Wound Management and a Fellow of the American College of Certified Wound Specialists. He is the founder of the “Save a Leg, Save a Life” Foundation, a multidisciplinary, non-profit organization dedicated to the reduction of lower extremity amputations and improving wound healing outcomes through evidence-based methodology and community outreach.
1. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg 1987; 40(2): 113-141.
2. Singh K. New treatment paradigm: the angiosome concept. Pod Today. 2012; 25(Suppl2):4-7.
3. Neville RF, Attinger CE, Bullan EJ, et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg. 2009; 23(3):367-373.
4. Iida O, Soga Y, Hirano K, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg. 2012; 55(2):363-370.